目的：测定罗红霉素的含量。
目的：测定人血浆中罗红霉素的含量。
Objective: To measure the content of roxithromycin in human blood plasma.
目的：评价2种罗红霉素胶囊的生物等效性。
AIM: To estimate the bioequivalence of 2 roxithromycin capsules.
目的：进行国产与进口罗红霉素的生物利用度研究。
AIM: To observe the relative bioavailability of domestic or import roxithromycin.
但小粒径罗红霉素缓释微丸具有更高的生物利用度。
But Roxithromycin sustained release pellets with smaller size show a better bioavailability.
目的：验证一种罗红霉素片微生物限度检查的方法。
Objective: To establish a microbial limit test method for Roxithromycin Tablets.
目的：建立测定罗红霉素电子药膜中主药含量的方法。
OBJECTIVE: To develop a method for assay of roxithromycin in electron medicinal membrane of roxithromycin.
前言：目的：研究罗红霉素涂膜剂的制备与临床应用。
Objective: To study the preparation and clinical application of roxithromycin plastics.
结论：罗红霉素可能具有一定的抗炎和免疫调节作用。
CONCLUSION: Roxithromycin may have anti-inflammation and immunoregulation effects.
结论对罗红霉素分散片进行方法学验证，结果符合药典要求。
Conclusion the results of methodological validation to Roxithromycin Dispersible Tablets are in line with the demand of the Chinese Pharmacopoeia.
目的制备治疗儿科疾病的罗红霉素中空栓剂并对其质量控制进行研究。
Objective to prepare Roxithromycin Hollow Suppository and to study its quality control in order to treat paediatric diseases.
国产罗红霉素对于所采用实验菌株的MBC要大于MIC的4～16倍。
The minimal bactericidal concentration(MBC) of roxithromycin was 4~16 times greater than the minimal inhibitory concentration(MIC).
罗红霉素为新型大环内酯类抗生素，其体外抗菌活性类似于母体化合物红霉素。
Roxithromycin, a new macrolide antibiotic, has an antibacterial spectrum similar to that of erythromycin.
目的：研究国产罗红霉素体外杭菌作用，并同大环内醋类其它杭生素进行比较。
OBJECTIVE: To investigate the in vitro activity of domestic roxithromycin and compare it with other macrolides.
目的：研究罗红霉素对免疫细胞功能的影响，探讨其除抗菌以外的抗炎和免疫调节作用。
OBJECTIVE: to study the effect of roxithromycin on cellular immune function and to study its anti-inflammatory and immunoregulation effects beside its antibacterial effect.
方法采用分光光度法测定罗红霉素胶囊的体外溶出度，并对溶出参数进行相关性分析。
Methods The dissolution of roxithromycin capsules was analyzed with spectrophotometry. The dissolutive parameters of different products were compared.
方法：选用壳聚糖为成膜材料，制备罗红霉素涂膜剂，并建立质量控制方法，进行临床疗效观察。
Methods: Chitosan was used to prepare the roxithromycin plastics. The quality controlling method was established and the clinical therapeutic effect was observed.
目的比较国产和进口罗红霉素分散片治疗儿科细菌感染性疾病的临床有效性、安全性和依从性疗效。
Objective To compare the clinical effectiveness, safety and compliance of import and domestic roxithromycin dispersible tablets in the treatment of bacterial infectious diseases of children.
本发明提供一种包含罗红霉素、替硝唑和维生素b2的药物及其制备方法。属于化学药物组合物领域。
The invention provides a medicament containing roxithromycin, tinidazole and vitamin B2 and a preparation method thereof, belonging to the field of chemical medicine compositions.
方法110例解脲支原体泌尿道感染患者随机分为：阿奇霉素组、 罗红霉素组、克拉霉素组等3组。
Methods:110 cases of mycoplasma urealytium genitourinary tract infection were randomly divided into 3 groups, group Azithromycin, group Roxithromycin, group Clarithromycin.
建立了罗红霉素新的TLC法，并与《日本抗生物质医药品基准解说》1993年版收载的方法进行了比较。
A novel TLC method of roxithromycin was compared with the TLC method which was described in "the Japanese Standards of Antibiotics (1993)".
方法以藤黄微球菌为检定菌，游标卡尺测量抑菌环直径，检测抑菌圈直径与血浆中罗红霉素浓度对数的线性关系。
METHODS Plasma roxithromycin concentration was determined by using micrococcus luteus as test strain, the inhibition zone diameter were examined detected to roxithromycin with vernier caliper.
结论罗红霉素能改善大鼠急性肺损伤时气体交换能力，调节肺部细胞因子，对内毒素诱导的急性肺损伤有保护作用。
CONCLUSION Roxithromycin has a protective effect on rat acute lung injury induced by LPS through regulating cytokines, improving gas exchange ability, and inhibiting lung permeability.
研究了以无水碳酸钠为催化剂，红霉素肟与甲氧基乙氧基氯甲醚(MEMC)为原料，一步合成罗红霉素的实验过程。
The experimental process on synthesis of roxithromycin was studied by using erythromycin oxime and MEMC as raw material under the catalytic action of anhydrous sodium carbonate.
阿奇霉素（或罗红霉素等）加利复星在SARS疑似患者中充分和规则治疗，对SARS的临床鉴别诊断具有重要作用。
Full and regular treatment with miramycin or Roxithromycin plus Levofloxacin is important role for differential diagnosis of SARS.
结果在测定的4种大环内酯类药物中，淋球菌对阿奇霉素敏感性最高，达100 %；其次为罗红霉素，为96。04 %。
Results of all these 4 macrolides, the higher susceptibilities to gonococci were azithromycin and roxithromycin, in turn, the percentages of susceptibility were 100 %, 96. 04 %, respectively.
结果在测定的4种大环内酯类药物中，淋球菌对阿奇霉素敏感性最高，达100 %；其次为罗红霉素，为96。04 %。
Results of all these 4 macrolides, the higher susceptibilities to gonococci were azithromycin and roxithromycin, in turn, the percentages of susceptibility were 100 %, 96. 04 %, respectively.
应用推荐